Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO872601Aexternal-prioritypatent/NO168174C/no
Publication of NO902562LpublicationCriticalpatent/NO902562L/no
Application filed by Du Pont Merck Pharma, Du PontfiledCriticalDu Pont Merck Pharma
Priority to NO902562ApriorityCriticalpatent/NO174255C/no
Publication of NO902562D0publicationCriticalpatent/NO902562D0/no
Publication of NO174255BpublicationCriticalpatent/NO174255B/no
Publication of NO174255CpublicationCriticalpatent/NO174255C/no
Fremgangsmade til fremstilling af 1-(2-heterocyclyl-2-(5-chlor-2-pyridyl)-2-hydroxy-ethyl)-1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf